TAG:
Thermo Fisher
Machine Learning Poised to Give Clinical Labs New Capabilities
By Robert Michel | From the Volume XXX, Number 16 – November 13, 2023 Issue
āOne of the first questions I ask the laboratory team is ādo you want to continue to be a factory or do you want to be a change agent in healthcare?ā They all answer that they want contribute to positive change.ā āMichael Simpson …
Is Lab and IVD Consolidation Ready to Hit the Wall?
By R. Lewis Dark | From the Volume XXX, No. 13 – September 11, 2023 Issue
IN HUMAN HISTORY, ALL ERAS COME TO AN END. The majority of the time, the end of an era is disruptive and a new status quo emerges, with different winners and losers. Today, there is growing evidence that one era in c…
Lab Briefs: Roche, GenMark Diagnostics, Thermo Fisher, Mesa Biotech, ProPath
By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue
Roche to Acquire GenMark Diagnostics LAST MONTH, Roche and GenMark Diagnostics announced a definitive merger agreement for Roche to acquire GenMark in a transaction valued at $1.8 billion.Ā …
Lab Buys More Instruments as Way to Add Test Volume
By Joseph Burns | From the Volume XXVII No. 9 – June 22, 2020 Issue
CEO SUMMARY: Severe shortages of supplies for COVID-19Ā lab testing caused one lab director in the Midwest to buy additionalĀ instruments while also validating five different COVID-19Ā tests to run on analyzers the lab used before the pandemic hit.Ā While this strategy allowed the lab to …
Two Collaborations: LabCorp-Thermo Fisher, Roche-Illumina
By Joseph Burns | From the Volume XXVII No. 2 – January 27, 2020 Issue
InĀ dealsĀ relatedĀ to Ā the Ā pursuit of companion diagnostics, two lab companies announced collaboration deals with companies that manufacture gene-sequencing equipment. The deals were announced on consecutive days earlier this month. Financial terms were not disclosed. On Jan. 13, Ro…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized